Luu T.

Commercial Partnerships | Business Development | Geographic Expansion in Life Sciences

📍 Switzerland🔄 Updated September 2026💼 1 investments📅 1 years investing🗓 Last invested Oct 2025
VC🌍 SwitzerlandInvested this year
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
1y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Experience · 4 entries
All (4)
Investments (1)
2026
Executive Director Distributor Management (Commercial Partnerships)
Jan 2026
Mirum Pharmaceuticals is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines deep rare disease expertise with strong connections to patient communities. The company’s commercial portfolio includes LIVMARLI® (maralixibat) for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile-acid synthesis disorders, and CTEXLI® (chenodiol) for cerebrotendinous xanthomatosis (CTX). Mirum’s clinical-stage pipeline includes volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), brelovitug, a fully human monoclonal antibody in late-stage development for chronic hepatitis delta virus (HDV) and MRM-3379, a PDE4D inhibitor being evaluated for Fragile X syndrome (FXS). Mirum’s success is driven by a team dedicated to advancing high impact medicines through strategic development, disciplined execution and purposeful collaboration across the rare disease ecosystem. Learn more at www.mirumpharma.com.
2025
2011
Associate Planning & Integration Director
Jan 2011
Shire is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/
2006
Business Development Analyst
Feb 2006
Nestlé Health Science is a leader in the science of nutrition, committed to redefining the management of health.  We offer an extensive portfolio of science-based consumer care, medical nutrition and pharmaceutical therapies.  Headquartered in Switzerland, we have more than 12,000 employees around the world, with products available in more than 140 countries. We see opportunities to improve health through nutrition everywhere. Our expertise areas of active lifestyle nutrition, including vitamins, minerals, herbals and supplements (VMHS), medical nutrition, and pharmaceutical solutions, are rooted in science and cover every facet of health: prevention, maintenance, and treatment. We are redefining the way consumers and healthcare professionals approach the management of health. With a focus on areas including food allergies, metabolic health, gastrointestinal health, healthy aging, and adult acute care, we leverage our extensive research and development networks to unlock the power of nutrition. The wide range of solutions we offer across the spectrum of life has one common denominator: science-based products that help people live their best lives.